News
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
More in Politics
- Judge Questions Secrecy Around Trump Administration’s Memo on Boat Strikes The New York Times — Politics
- Fed watchdog clears former chair Powell in renovation probe Axios
- Dems block data center electricity bill, calling it 'toothless' The Hill
- The Guardian view on falling pupil numbers: a chance to improve opportunities for young people | Editorial The Guardian — Politics
- Trump officials changed forms for overseas voters amid a GOP push to restrict voting NPR — Politics